Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cancer cell intrinsic TIM-3 induces glioblastoma progression
Qing Guo, Shuai Shen, Gefei Guan, et al.
iScience (2022) Vol. 25, Iss. 11, pp. 105329-105329
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

TIM-3 as a promising target for cancer immunotherapy in a wide range of tumors
Natalia Sauer, Natalia Janicka, Wojciech Szlasa, et al.
Cancer Immunology Immunotherapy (2023) Vol. 72, Iss. 11, pp. 3405-3425
Open Access | Times Cited: 66
Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives
Hao Lin, Chaxian Liu, An-Kang Hu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 62
TIM-3 blockade in diffuse intrinsic pontine glioma models promotes tumor regression and antitumor immune memory
Iker Ausejo‐Mauleon, Sara Labiano, Daniel de la Nava, et al.
Cancer Cell (2023) Vol. 41, Iss. 11, pp. 1911-1926.e8
Open Access | Times Cited: 50
Immunotherapy for glioblastoma: current state, challenges, and future perspectives
Yang Liu, Zhou Fei, Heba Ali, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 12, pp. 1354-1375
Open Access | Times Cited: 22
ALKBH5 acts a tumor-suppressive biomarker and is associated with immunotherapy response in hepatocellular carcinoma
Hehua Ma, Yuxin Hong, Zhenzhen Xu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Soluble TIM-3 as a biomarker of progression and therapeutic response in cancers and other of human diseases
Christian Bailly, Xavier Thuru, Laurence Goossens, et al.
Biochemical Pharmacology (2023) Vol. 209, pp. 115445-115445
Open Access | Times Cited: 21
The Recent Research Progress of NF-κB Signaling on the Proliferation, Migration, Invasion, Immune Escape and Drug Resistance of Glioblastoma
Pengfei Shi, Jie Xu, Hongjuan Cui
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 10337-10337
Open Access | Times Cited: 21
The Glioma Immune Landscape: A Double-Edged Sword for Treatment Regimens
Sukrit Mahajan, Mirko H. H. Schmidt, Ulrike Schumann
Cancers (2023) Vol. 15, Iss. 7, pp. 2024-2024
Open Access | Times Cited: 17
Recent Advances in Biomimetic Strategies for the Immunotherapy of Glioblastoma
Haoyu You, Shuo Geng, Shangkuo Li, et al.
Biomaterials (2024) Vol. 311, pp. 122694-122694
Closed Access | Times Cited: 8
Diffuse intrinsic pontine glioma (DIPG): A review of current and emerging treatment strategies
Luke J. Weisbrod, Thiraviyam Anand, Raghupathy Vengoji, et al.
Cancer Letters (2024) Vol. 590, pp. 216876-216876
Closed Access | Times Cited: 7
Co-expression of immune checkpoints in glioblastoma revealed by single-nucleus RNA sequencing and spatial transcriptomics
Dingyi Yuan, Wenting Chen, Shasha Jin, et al.
Computational and Structural Biotechnology Journal (2024) Vol. 23, pp. 1534-1546
Open Access | Times Cited: 6
A Roadmap of CAR-T-Cell Therapy in Glioblastoma: Challenges and Future Perspectives
Megan Montoya, Marco Gallus, Su Phyu, et al.
Cells (2024) Vol. 13, Iss. 9, pp. 726-726
Open Access | Times Cited: 6
The role of Tim-3 blockade in the tumor immune microenvironment beyond T cells
Jie Zhang, Longsheng Wang, Hongjie Guo, et al.
Pharmacological Research (2024) Vol. 209, pp. 107458-107458
Open Access | Times Cited: 6
Targeting tumor-associated macrophages: Novel insights into immunotherapy of skin cancer
Jun Liu, Jiaye Lu, Ling Wu, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 5
Combined cytotoxic and immune-stimulatory gene therapy using Ad-TK and Ad-Flt3L: Translational developments from rodents to glioma patients
Syed Mohd Faisal, María G. Castro, Pedro R. Löwenstein
Molecular Therapy (2023) Vol. 31, Iss. 10, pp. 2839-2860
Open Access | Times Cited: 12
CD2AP promotes the progression of glioblastoma multiforme via TRIM5-mediated NF-kB signaling
Liang Zhang, Jiawei He, Wentao Zhao, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 10
Open Access | Times Cited: 4
The Role of TIM-3 in Glioblastoma Progression
Farah Ahmady, Amit Sharma, Adrian Achuthan, et al.
Cells (2025) Vol. 14, Iss. 5, pp. 346-346
Open Access
Suppressive immune microenvironment and CART therapy for glioblastoma: Future prospects and challenges
Jie Lu, Wen Huo, Yingze Ma, et al.
Cancer Letters (2024) Vol. 600, pp. 217185-217185
Open Access | Times Cited: 3
Single-nucleus RNA sequencing reveals a preclinical model for the most common subtype of glioblastoma
Laura García-Vicente, María Martínez-Fernández, Michael Borja, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access
TIM-3 teams up with PD-1 in cancer immunotherapy: mechanisms and perspectives
Zhuohong Yan, Chunmao Wang, Jinghong Wu, et al.
Molecular Biomedicine (2025) Vol. 6, Iss. 1
Open Access
Interactions between cancer cells and tumor-associated macrophages in tumor microenvironment
Lu Liu, Yafei Li, Bo Li
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189344-189344
Closed Access
Combination of loco-regional radiotherapy with a TIM-3 aptamer improves survival in diffuse midline glioma models
Iker Ausejo‐Mauleon, Naiara Martínez-Vélez, Andrea Lacalle, et al.
JCI Insight (2024) Vol. 9, Iss. 18
Open Access | Times Cited: 2
Recent Developments in Glioblastoma‐On‐A‐Chip for Advanced Drug Screening Applications
Surjendu Maity, Tamanna Bhuyan, Christopher M. Jewell, et al.
Small (2024)
Open Access | Times Cited: 2
‘Slicing’ glioblastoma drivers with the Swiss cheese model
Oriana Y. Teran Pumar, Justin D. Lathia, Dionysios C. Watson, et al.
Trends in cancer (2023) Vol. 10, Iss. 1, pp. 15-27
Open Access | Times Cited: 6
CD8+CD103+PD1+TIM3+ T cells in glioblastoma microenvironment correlate with prognosis
Giulia Romagnoli, Quintino Giorgio D’Alessandris, Imerio Capone, et al.
Immunology (2023) Vol. 171, Iss. 2, pp. 198-211
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top